Emery P, McInnes I, Mease P, Schiff M, Pricop L, Shen S, Wang Z, Gaillez C. Secukinumab Sustains Individual Clinical Responses Over Time in Patients with Psoriatic Arthritis: 2-Year Results from a Phase 3 Trial. J of Skin [Internet]. 2018 Feb. 23 [cited 2024 Jul. 4];2(S1):S21. Available from: https://jofskin.org/33014/index.php/skin/article/view/293